Mpox Vaccination Hesitancy, Previous Immunization Coverage, and Vaccination Readiness in the African Region | Global Prevalence and Correlates of Mpox Vaccine Acceptance and Uptake |
The Effect of Nirmatrelvir/ritonavir on Short- and Long-term Adverse Outcomes from COVID-19 |
Epidemiological Insights into Chronic Urticaria, Vitiligo, Alopecia Areata, and Herpes Zoster following COVID-19 Infection | Impact of Extended-course Oral Nirmatrelvir/ritonavir in Established Long COVID
In-hospital Outcomes of Healthcare-associated Coronavirus Disease 2019 (Omicron) Versus Healthcare-associated Influenza: A Retrospective, Nationwide Cohort Study in Switzerland | Real Clinical Effectiveness of Molnupiravir Against 30-day Mortality Among 74, 41 SARS-CoV-2–Positive Patients: A Nationwide Cohort Study from the Czech Republic
On January 20, 2012, the first NTDS road map was launched, along with the formation of the world’s biggest public-private sector partnership and significant and substantial pledges.
World Neglected Tropical Diseases Day is January 30th Read More »
The Burden of All-Cause Mortality Following Influenza-Associated Hospitalizations | Initial Effectiveness of mRNA-1273 against SARS-CoV-2 Infection | 2024 Update of the RECOVER-Adult Long COVID Research Index | Real-world Effectiveness and Causal Mediation Study of BNT162b2 |
Personality and Neuropsychiatric Symptoms in Individuals Diagnosed with Long COVID | Post-COVID Condition Risk Factors and Symptom Clusters
BNT162b2 XBB Vaccine for COVID-19 Among Children 5-17 Years of Age | Post-acute Sequelae of COVID-19 in Cancer Patients: Two Cohorts in UK and Hong Kong
Trial Stops Enrollment after Tpoxx Fails to Speed Clade 2 Mpox Healing or Pain Relief | Relative Effectiveness of Homologous NVX-CoV2373 and BNT162b2 COVID-19 Vaccinations in South Korea
Estimated Effectiveness of Influenza Vaccines | Benefit of Early Oseltamivir Therapy for Adults | Maternal Infection of SARS-CoV-2 | The Effect of Pre-COVID and Post-COVID Vaccination |
Delayed Induction of Noninflammatory SARS-CoV-2 Spike-Specific IgG4 Antibodies | Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations |
Remdesivir Effectiveness in Reducing the Risk of 30-day Readmission |
Transcutaneous Electrical Nerve Stimulation for Fibromyalgia-like Syndrome | Mitigating the Risks of Post-acute Sequelae of SARS-CoV-2 Infection | Measurement of Circulating Viral Antigens Post-SARS-CoV-2 Infection
Global mission to eliminate five devastating parasitic diseases through research, education, and international cooperation, targeting Guinea Worm, Malaria, River Blindness, Polio, and Lymphatic Filariasis.
The Journey to Zero of Parasitic Diseases is a Global Task Read More »
Association between Use of a Voluntary Isolation Centre and Reduced Household SARS-CoV-2 Transmission |
Risks of SARS-CoV-2 JN.1 Infection and COVID-19–Associated Emergency Department Visits | Real Clinical Effectiveness of Molnupiravir against 30-day Mortality | Time to Sustained Recovery Among Outpatients With COVID-19 | Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 | Remdesivir for 5 or 10 Days in Patients | Remdesivir for Treatment of COVID-19 | Neurologic Manifestations of Long COVID Disproportionately Affect Young and Middle-age Adults
Serological Evidence of Mpox Virus Infection During Peak Mpox Transmission in New York City, July to August 2022 | N95 Filtering Facepiece Respirator Reuse, Extended Use, and Filtration Efficiency | Enhanced Placental Antibody Transfer Efficiency with Longer Interval Between Maternal RSV Vaccination and Birth
A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.
Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.
English 
Spanish